HORMONAL TREATMENTS FOR BREAST CANCER (ALL
drug has been approved by the FDA (Food and Drug
Administration) for the treatment of metastatic
(Stage IV) breast cancer.
mg (1 tablet) four times per day.
|Duration and timing:
In the treatment of stage IV disease treatment is
continued until disease progression.
possible nausea and vomiting (which may
be decreased or prevented with
medications), appetite stimulation,
fluid retention, edema, tumor flare,
hypercalcemia (high calcium levels),
hyperglycemia (high glucose levels) and
resistance to insulin has been seen.
adverse effect on fertility is known;
this drug should not be taken by women
who are pregnant or breast feeding.
instances of pulmonary embolism have
occurred (blood clot going to the lung),
dyspnea (feeling of shortness of breath).
episodes of vaginal discharge and
breakthrough bleeding have been noted.
elevated liver enzymes.
increased risk of developing blood clots.
1997 - TransMed Network